Patients with chronic spontaneous urticaria who used ligelizumab reported improvements in their sleep quality compared with patients who received omalizumab or placebo, according to a study published in Clinical and Translational Allergy.
Sleep interference impairs cognitive function at work and elsewhere, impacts social lives and increases the risk for comorbidities such as cardiovascular disease and reduced life expectancy, Ana Giménez-Arnau, MD, PhD, professor of dermatology at Universitat Autònoma in Barcelona, and colleagues wrote.
The phase 2b study involved 297 adults with moderate to